Recent advances in triazoles as tyrosinase inhibitors.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
05 Nov 2023
Historique:
received: 30 05 2023
revised: 10 07 2023
accepted: 13 07 2023
medline: 22 8 2023
pubmed: 24 7 2023
entrez: 23 7 2023
Statut: ppublish

Résumé

The tyrosinase enzyme, which is widely found in microorganisms, animals and plants, has a significant position in melanogenesis, plays an important role in undesirable browning of fruits and vegetables, antibiotic resistance, skin pigment formation, sclerotization of cuticle, neurodegeneration, etc. Therefore, with the wide potential application fields of tyrosinase in food, agriculture, cosmetics and pharmaceutical industries, which has become the target enzyme for the development of therapeutic agents such as antibrowning, anticancer, antibacterial, skin whitening, insecticides, etc., a large number of synthetic tyrosinase inhibitors have been widely reported in recent years. The triazole ring, which has a broad spectrum of biological action, is of increasing interest in the synthesis of new tyrosinase inhibitors. In this review, tyrosinase inhibition effects, structure-activity relationships, enzyme inhibition kinetics and mechanisms of action of 1,2,3- or 1,2,4-triazole derivatives were investigated. The data gathered is anticipated to supply rational guidance and an influential strategy for the development of novel, potent and safe tyrosinase inhibitors for better practical application in the future.

Identifiants

pubmed: 37482020
pii: S0223-5234(23)00621-9
doi: 10.1016/j.ejmech.2023.115655
pii:
doi:

Substances chimiques

Enzyme Inhibitors 0
Monophenol Monooxygenase EC 1.14.18.1
Triazoles 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

115655

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Arif Mermer (A)

Experimental Medicine Application & Research Center, Validebağ Research Park, University of Health Sciences, İstanbul, Turkiye; Department of Biotechnology, University of Health Sciences, İstanbul, Turkiye. Electronic address: arif.mermer@sbu.edu.tr.

Serpil Demirci (S)

Department of Medical Services and Techniques, Vocational High School of Health Services, Giresun University, Giresun, Turkiye.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH